RADx-UP Phase 3D (Oregon Saludable: Juntos Podemos)

NAActive, not recruitingINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

April 22, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Health BehaviorHealth Care UtilizationVaccine Hesitancy
Interventions
BEHAVIORAL

Self-Affirmation Implementation Intentions (SAII) Intervention

"In an brief exercise, participants are asked to provide a personal story and positive experience during the challenging and sometimes stressful COVID19 pandemic, …a time when you felt successful and proud of yourself. …You can also tell us about a time that you did something to help someone in need. The self-affirmation is designed to offset effects of threats to self. In the next section participants are asked to formulate an if-then plan with one preferred self-affirmation-inducing cognition: If I feel sad, threatened, or discriminated against, then I will… a)…think about things I value about myself, b)…remember things that I have succeeded in, c) …think about what I stand for, or d)…think about things that are important to me. After selecting response, participants read the full If-Then plan out loud and are provided with a paper copy of their exercise to take home."

BEHAVIORAL

Promotores de Salud (Health Education)

The Promotores de Salud intervention includes: (1) a culturally tailored health education to increase knowledge about COVID-19 and the benefits of testing; (2) motivational interviewing (MI) strategies to explore personal, social, and behavioral barriers to testing and to discuss available resources to resolve these barriers; (3) emotional support to address testing-related concerns and anxieties that may dissuade Latinx individuals from getting tested; and (4) service navigation. When promotores (community health advocates) are on-site at Mexican Consulate events, they will provide information about COVID-19 and preventive behaviors using in-person instruction on effective mask wearing, hand washing, and physical distancing, as well as the importance of repeated testing and vaccines.

Trial Locations (1)

97403

University of Oregon, Eugene

All Listed Sponsors
collaborator

National Institute on Minority Health and Health Disparities (NIMHD)

NIH

lead

University of Oregon

OTHER